Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Complete Response letter related to the BLA for azficel-T offered to Fibrocell Science

Fibrocell Science, Inc. announced today that it has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) related to the Biologics License Application (BLA) for azficel-T, an autologous cell therapy for the treatment of moderate to severe nasolabial fold wrinkles in adults.

22 Dec 2009

Bioject Medical Technologies completes a Series G Preferred Stock financing

Bioject Medical Technologies Inc., a leading developer of needle-free injection therapy systems, today announced that on December 18, 2009, it completed a Series G Preferred Stock financing with each of Life Sciences Opportunities Fund II, L.P., Life Sciences Opportunities Fund (Institutional) II, L.P. (collectively, the “LOF”), and Edward Flynn for the purchase of an aggregate of 92,448 shares of its Series G Convertible Preferred Stock at a price of $13.00 per share.

21 Dec 2009

Sanofi-aventis to acquire Chattem for $1.9 billion

Sanofi-aventis and Chattem, Inc. announced today that they have entered into a definitive agreement under which sanofi-aventis is to acquire 100 percent of the outstanding shares of Chattem in a cash tender offer for $93.50 per share, or approximately $1.9 billion.

21 Dec 2009

Positive interim results from Medicago's H5N1 vaccine Phase I human clinical trial

Medicago Inc. a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive interim results from a Phase I human clinical trial with its H5N1 Avian Influenza vaccine candidate ("H5N1 vaccine"). The vaccine was found to be safe, well tolerated and also induced a solid immune response.

21 Dec 2009

Seattle Genetics and GSK sign ADC collaboration agreement

Seattle Genetics, Inc., announced today that it has entered into a collaboration agreement with GlaxoSmithKline (GSK) under which GSK will pay an upfront fee of $12 million for rights to utilize Seattle Genetics’ antibody-drug conjugate (ADC) technology with multiple antigens to be named by GSK.

21 Dec 2009

USANA Health Sciences announces partnership with EVE as the event’s Rail Jam sponsor

USANA Health Sciences, Inc. is proud to announce its partnership with EVE as the event’s Rail Jam sponsor. EVE is Salt Lake City’s premier New Year celebration and will take place in the heart of downtown on December 29, 30 and 31.

19 Dec 2009

New ways of treating infections identified by researchers at Binghamton University

Researchers at Binghamton University, State University of New York, have identified three key regulators required for the formation and development of biofilms. The discovery could lead to new ways of treating chronic infections.

19 Dec 2009

Mannatech patent infringement: U.S. Judge grants injunction against Green Life and Xiong Lo

Mannatech, Incorporated, a global pioneer in the development of high-quality health, weight and fitness, and skin care solutions based on nutritional science, obtained a judgment finding that Green Life, LLC (Green Life), and Xiong Lo (Lo) infringed Mannatech patents (U.S. Patents 6,929,807; 7,157,431; 7,196,064; 7,199,104; and 7,202,220).

18 Dec 2009

Jubilant Organosys announces new facility for Niacinamide and 3-Cyanopyridine

Jubilant Organosys Limited, an integrated pharmaceutical industry player and the largest Custom Research and Manufacturing Services Company in India, announced today that it is setting up Niacinamide and 3-Cyanopyridine plant of 10,000 TPA each, expected to be ready by end of 2010.

18 Dec 2009

Patheon announces fiscal 2009 fourth-quarter and full-year financial results

Patheon a global provider of drug development and manufacturing services to the international pharmaceutical industry today announced results for the fourth quarter and full year ended October 31, 2009.

18 Dec 2009

Liquidia Technologies to receive $3 million in funding from NIST

Liquidia Technologies today announced it will receive approximately $3 million in funding from the U.S. Commerce Department’s National Institute of Standards and Technology (NIST) to further develop and scale-up the company’s PRINT manufacturing process.

18 Dec 2009

Large-scale genomic sequencing of microbes and ecosystems proposed for greatest impact in medicine

Scientists can gain insights into new ways to use microorganisms in medicine and manufacturing through a coordinated large-scale effort to sequence the genomes of not just individual microorganisms but entire ecosystems, according to a new report from the American Academy of Microbiology that outlines recommendations for this massive effort.

18 Dec 2009

Plans moving forward for Medizone International's hospital sterilization system, AsepticSure

Medizone International, Inc. Chairman of the Board and Chief Executive Officer, Edwin Marshall, today outlined the company's plans moving forward for its hospital sterilization system, AsepticSure(TM).

18 Dec 2009

USDA joins global alliance to reduce greenhouse gas emissions, increase food security

The U.S. Agriculture Department (USDA) said on Wednesday it has joined the Global Research Alliance, which aims to reduce greenhouse gas emissions and increase access to food worldwide, Reuters reports.

17 Dec 2009

AlphaRx, Venturepharm sign supply agreement for ARX1088's API

AlphaRx Inc. announced today that it has signed an agreement that provides long-term supply of the active pharmaceutical ingredient (API) for ARX1088, an orally active interferon inducer intended for the adjunctive treatment of Hepatitis in China and other emerging markets. Under the agreement, Venturepharm will be the primary supplier of AlphaRx's worldwide requirements for the compound.

17 Dec 2009

Sonomax Hearing Healthcare attains Phase IV milestone in its off-the-shelf, custom earpieces development

Sonomax Hearing Healthcare Inc. attains the Phase IV milestone and is only one milestone away from successfully completing the development of its off-the-shelf, self-fitting custom earpieces.

17 Dec 2009

Therapure Biopharma to fill/finish nimotuzumab at its Canadian GMP certified fill suite

David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized monoclonal antibody licensed to YM's majority-owned Canadian subsidiary, CIMYM BioSciences Inc., by the Centre of Molecular Immunology (CIM).

17 Dec 2009

Avecia Biologics to be acquired by Merck

Merck & Co. Inc., (operating in the United Kingdom as MSD) and Avecia Investments Limited today announced that they have entered into a definitive agreement by which Merck will acquire the biologics business of the Avecia group through a Merck affiliate (Merck Sharp & Dohme (Holdings) Limited or "MSD"). Avecia Biologics is a contract manufacturing organization with specific expertise in microbial-derived biologics. Financial details of the transaction were not disclosed.

17 Dec 2009

Unilife Medical Solutions to construct new global headquarters and commercial production facility

Unilife Medical Solutions Limited (Unilife or the Company) today announced the signing of agreements for the construction of its new global headquarters and commercial production facility in York, Pennsylvania.

17 Dec 2009

USANA Health Sciences announces partnership with Utah Grizzlies

USANA Health Sciences, Inc. is proud to announce its partnership with the Utah Grizzlies as the team’s official nutritional supplement provider.

17 Dec 2009

Manufacturing News and Research

Further Reading

Complete Response letter related to the BLA for azficel-T offered to Fibrocell Science

Bioject Medical Technologies completes a Series G Preferred Stock financing

Sanofi-aventis to acquire Chattem for $1.9 billion

Positive interim results from Medicago's H5N1 vaccine Phase I human clinical trial

Seattle Genetics and GSK sign ADC collaboration agreement

USANA Health Sciences announces partnership with EVE as the event’s Rail Jam sponsor

New ways of treating infections identified by researchers at Binghamton University

Mannatech patent infringement: U.S. Judge grants injunction against Green Life and Xiong Lo

Jubilant Organosys announces new facility for Niacinamide and 3-Cyanopyridine

Patheon announces fiscal 2009 fourth-quarter and full-year financial results

Liquidia Technologies to receive $3 million in funding from NIST

Large-scale genomic sequencing of microbes and ecosystems proposed for greatest impact in medicine

Plans moving forward for Medizone International's hospital sterilization system, AsepticSure

USDA joins global alliance to reduce greenhouse gas emissions, increase food security

AlphaRx, Venturepharm sign supply agreement for ARX1088's API

Sonomax Hearing Healthcare attains Phase IV milestone in its off-the-shelf, custom earpieces development

Therapure Biopharma to fill/finish nimotuzumab at its Canadian GMP certified fill suite

Avecia Biologics to be acquired by Merck

Unilife Medical Solutions to construct new global headquarters and commercial production facility

USANA Health Sciences announces partnership with Utah Grizzlies

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News